Magnys Life Sciences Private Limited
About Magnys Life Sciences Private Limited
Data last updated:
Magnys Life Sciences Private Limited was a private limited company based in Thane, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 August 2017.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC298669. Its GSTIN is 36AALCM2674A1ZK (Telangana).
The company had an authorised share capital of ₹35 Lakh and a paid-up capital of ₹35 Lakh. It was led by directors including Ganesh Jayaraman and Kozhappilly Narayanan Kutty.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 303 Saylee Chs Ltd Mhada Swami Vivekanand Nagar Sandozbaugh, Thane, Maharashtra, India – 400607.
As per the financials filed for FY 2018, the company reported a revenue of ₹45,000. For the same year it recorded a net loss of ₹2.44 Lakh and EBITDA of -₹2.43 Lakh.
Company details
Contact details
Magnys Life Sciences Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address303 Saylee Chs Ltd Mhada Swami Vivekanand Nagar Sandozbaugh, Thane, Maharashtra, India – 400607
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Magnys Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Magnys Life Sciences Private Limited
FY 2023 filings availableMagnys Life Sciences Private Limited reported revenue of ₹45,000 for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹45,000 |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹2.43 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹2.44 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Magnys Life Sciences Private Limited, buy the company report.
Board of directors of Magnys Life Sciences Private Limited
Magnys Life Sciences has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganesh Jayaraman | Director | 16 Aug 2017 | 9 Years 2 Months | As last reported |
| Kozhappilly Narayanan Kutty Also directs: Hometek Realcon LLP, Xander Pharmaceuticals Private Limited, Eptas Enterprises Private Limited and 1 more | Director | 16 Aug 2017 | 9 Years 2 Months | As last reported |
| Suresh Kumar Bhaskaran Nair Also directs: Sargatma Construction Private Limited | Director | 16 Aug 2017 | 9 Years 2 Months | As last reported |
Auditor
Magnys Life Sciences Private Limited is audited by Mayur Jadhav and Associates for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mayur Jadhav and Associates | FY 2018 |
Shareholding
The shareholding of Magnys Life Sciences Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Magnys Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Magnys Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Magnys Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Magnys Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AALCM2674A1ZK | Telangana | Active | 30 Sep 2017 |
To see the full GST registrations and return filing status of Magnys Life Sciences Private Limited, buy the company report.
Recent activity
Magnys Life Sciences Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Ganesh Jayaraman was appointed as Director on 16 Aug 2017.
Frequently asked questions
Magnys Life Sciences has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Magnys Life Sciences was a private limited company based in Thane, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 August 2017 and is registered under CIN U24304MH2017PTC298669. The company has been struck off by the Registrar of Companies and is no longer operational.
Magnys Life Sciences had 3 directors:
- Ganesh Jayaraman - Director
- Kozhappilly Narayanan Kutty - Director
- Suresh Kumar Bhaskaran Nair - Director
The CIN (Corporate Identification Number) of Magnys Life Sciences is U24304MH2017PTC298669. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Magnys Life Sciences is at 303 Saylee Chs Ltd Mhada Swami Vivekanand Nagar Sandozbaugh, Thane, Maharashtra, India – 400607.
Magnys Life Sciences was incorporated on 16 August 2017. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Magnys Life Sciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Magnys Life Sciences is 36AALCM2674A1ZK, registered in Telangana.
Magnys Life Sciences operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Ganesh Jayaraman was appointed as Director on 16 Aug 2017. Kozhappilly Narayanan Kutty was appointed as Director on 16 Aug 2017. Suresh Kumar Bhaskaran Nair was appointed as Director on 16 Aug 2017.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
